Skip to main content

Spica Therapeutics

Antwerp, Belgium

Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.

$11.4M raised
Jun 2025
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spica Therapeutics

How much funding has Spica Therapeutics raised?
Spica Therapeutics has raised $11.4M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Who are Spica Therapeutics's investors?
Spica Therapeutics's investors include Qbic Fund, Bioqube Ventures, PMV.
Where is Spica Therapeutics headquartered?
Spica Therapeutics is headquartered in Antwerp, Belgium.
What does Spica Therapeutics do?
Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.
What stage is Spica Therapeutics at?
Spica Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Spica Therapeutics — Funding & Investors." VCBacked, June 4, 2025, https://www.vcbacked.co/company/spica-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Spica Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/spica-therapeutics
Wikipedia (cite web)
{{cite web |title=Spica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spica-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .